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Summary 
Normal human bone marrow, cultured in vitro with interleukin 5 to promote osinophil production 
and maturation, was inoculated with cell-free isolates of human immunodeficiency virus type 
1 (HIV-1). CD4 expression by eosinophil precursors, determined by immunocytochemistry, was 
found to be greatest early in their maturation with a rapid decline after 28 d in culture. Productive 
HIV infection of eosinophil precursors was detected 14 d after inoculation, by a combination 
of immunostaining for HIV-1 p24 and gp41/160 and in situ hybridization for viral RNA, together 
with assay of culture supernatants for p24 antigen and reverse transcriptase activity. Thus, eosinophils 
are susceptible to productive HIV-1 infection in vitro and may be an important reservoir for 
the virus in vivo. 
H uman immunoddidency viruses (HIV-1 and HIV-2) are known to infect in vivo cells bearing the CD4 glyco- 
protein surface receptor (1). These indude both T helper lym- 
phocytes and also cells of the monocyte/macrophage series. 
Infection of these cells is believed to be the major cause of 
immune deficiency seen in the later stages of HIV infection. 
However, several other cell types are known to express mem- 
brane CD4 and are, therefore, potential targets for HIV in- 
fection. For example, eosinophils i olated from peripheral blood 
of patients with eosinophilia have been shown to express CD4 
on their surface, to which HIV-1 gp 120 will bind in vitro 
(2), although HIV infection of these cells has not previously 
been reported. 
Eosinophils are granulocytic leukocytes derived from bone 
marrow stem cells and, like macrophages, they migrate rap- 
idly from peripheral blood into tissues, where they may sur- 
vive for several weeks (3). Although in vivo functions of eo- 
sinophils are not fully understood, their numbers, both in 
blood and tissues, increase greatly in response to parasitic in- 
fections (4). Thus, the possibility that eosinophils are infected 
by HIV in vivo would have important implications for the 
pathogenesis of HIV disease, particularly in tropical coun- 
tries where both HIV and parasitic infections are widespread. 
For this reason we have investigated the potential for eo- 
sinophils to support HIV infection by attempting to infect 
normal human eosinophil precursors with HIV-1 strains in 
vitro. 
Materials and Methods 
Bone Marrow Culture and Infection with HIVI. Normal human 
bone marrow samples were obtained, with informed consent, from 
five healthy volunteers by iliac crest aspiration. Mononuclear cells 
were separated bycenttifugation ver HcoH and suspended in IMDM 
containing 15% FCS, at 10 ~ cells/ml. Human rlL-5 (Glaxo Group 
Research Ltd., Greenford, UK) was added at 2 ng/ml to promote 
eosinophil differentiation (5). Cells were cultured for up to 56 d 
in 96-well microtitre plates (I(P cells in 100/~l/well), at 37~ in 
95% air/5% COs. To infect the cultured cells with HIV, cell-free 
supernatants of the R.F, RUT, and IIIB strains of HIV-1 (MILC 
AIDS Directed Programme) were added at a concentration of 104 
tissue culture infectious doses (TCtD)/ml, 7-21 d after the start 
of the cultures. 
Detection of Eosinophil CD4, HIV Antigens, and RNA. Antigen 
expression by the maturing eosinophil precursors was detected by 
immunostaining ofcytospin slides prepared at 7-d intervals, using 
the alkaline phosphatase anti-alkaline phosphatase technique with 
fast red substrate and hematoxylin counterstain (6). Separate slides 
at each time-point were stained with mAbs to CD4 (Dakopatts, 
High Wycombe, UK), and HIV p24 core protein (MRC EH12) 
and gp41/160 envelope glycoprotein (MtLC ADP330). The per- 
centage of maturing eosinophils expressing CD4 was determined 
as a function of time in control, uninfected cultures by examining 
100 cells on each slide. CD4 expression was quantitated by scoring 
each cell on an arbitrary scale from 0 to 3 according to the intensity 
of staining by anti-CD4 antibody. HIV-1 RNA was detected in 
infected cells by in situ hybridization using a specific 3sS-DNA 
probe (BH10), with carbol chromotrope treatment o block 
nonspecific staining of eosinophils (7). 
Detection of ViralReI~lication. 50-/zl aliquots of culture superna- 
tant was removed from each well at weekly intervals and replaced 
with fresh medium. Supernatants were stored at - 70~ and sub- 
sequently assayed for reverse transcriptase (KT) activity (8), for HIV 
p24 antigen level measured by F.LISA (Coulter Immunology, l.uton, 
UK) and for infectivity, assessed by coculture with Jurkat T cells. 
Supematants from the cocultures were assayed for I~T activity at 
dayS. 
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Bone Marrow Culture and Eosinophil CD4 Expression. After 
21 d in culture, >95% of surviving calls were eosinophil 
precursors. These ceils developed gradually from early pro- 
myelocytes seen at day 7, through to mature, terminally 
differentiated eosinophils after 56 d in culture, as assessed mor- 
phologically. CD4 expression by control, uninfected eosino- 
phil precursors was maximal in terms of both percentage and 
intensity during the first 28 d in culture, with a gradual de- 
cline to almost undetectable levels by 56d (Fig. 1). 
HIV Antigen and RNA Expression by Eosinophils. Fig. 2 
shows a 35-d-old culture, 21 d after infection with HIV-1 
ILF strain, stained as described above for p24 antigen. In- 
fected eosinophils expressed p24 predominantly ontheir cell 
membrane and a similar pattern was observed when stained 
for gp41/160. In situ hybridization confirmed the presence 
of HIV RNA in infected eosinophils (Fig. 3). Control, unin- 
fected cultures were negative for both HIV antigen and RNA 
expression (not shown). Eosinophil precursors first showed 
evidence of infection 14 d after the addition of viral inoculum. 
A maximum of 4% of the cells stained positively for either 
antigen or RNA. Infection of eosinophils was observed in 
two cultures infected with HIV-1 RF strain and one with 
Figure 1. CD4 expression by uninfected eosinophil precursors in cul-
ture. Normal human bone marrow was cultured in the presence of IbS, 
and CD4 expression was assessed at weekly intervals by staining cytospin 
slides with anti-CD4 mAbs. (~p) The percentage ofmaturing eosinophils 
expressing CD4 plotted against days in culture. The CD4 score (bottom) 
was derived by scoring 100 cells at each time-point on a scale from 0 to 
3 according to the intensity of staining. 
Figure 2. P24 antigen expression by 
HIV-1 RF-infected eosinophils. Normal 
human bone marrow was cultured in 
the presence ofIb5 and inocuhted with 
HIV-1 RF supernatant after 14 d. Cells 
were harvested 21 d later and stained 
with anti-p24 mAbs using the APAAP 
technique with fast red substrate to 
stain positive calls red. An infected eo- 
sinophil is hown in the center of the 
picture. 
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Figure 3. HIV-1 RNA expression by
HIV-1 RF-infected osinophils. Normal 
human bone marrow as cultured in
the presence of IL-5 and inoculated with 
HIV-1 RF supernatant fter 14 d. Cells 
were harvested 14d later and subjected 
to in situ hybridization with 35S-DNA 
HIV-1 probe (BH10) as described. Two 
infected eosinophils are shown together 
with uninfected cells. 
HIVol RUT, but in neither of two cultures inoculated with 
HIV-1 IIIB. 
Viral Replication. Productive infection of eosinophil cul- 
tures was confirmed by rising levels of IKT activity in the 
supernatant, beginning 7 d after viral inoculation and con- 
tinuing up to 49 d after inoculation, by which time all sur- 
viving eosinophils were morphologically mature (Fig. 4). No 
RT activity was detected incontrol culture supernatant. Par- 
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IKT activity in eosinophil culture supernatant fter infection Figure 4. 
with HIV-1. Normal human bone marrow as cultured in the presence 
of 1I.-5 and inoculated with HIV-1 RF supernatant f er 14 d. Culture 
supernatant was withdrawn atweekly intervals and assayed for RT ac- 
tivity as described. RT activity (cpm/ml) isplotted against days after in- 
oculation. 
aUel rises in p24 antigen levels were found in the infected 
culture supernatants (data not shown). Jurkat cocuhure x- 
periments confirmed the presence of infectious virus in the 
supernatants for up to 42 d after infection. 
Discussion 
These studies have shown for the first time that eosinophils 
can be infected by HIV-1 and support active replication of 
the virus, thus extending the work of Lucey et al. (2). We 
chose to use Ib5-stimulated bone marrow cultures as a source 
of actively dividing eosinophil precursors, in view of the 
difficulties associated with obtaining purified peripheral blood 
eosinophils from normal individuals in sufficient quantities 
(9). We carried out preliminary experiments on peripheral 
blood eosinophils i olated from hyper-eosinophilic subjects, 
but were unable to infect such cells with HIV or to transfect 
them with HIV-LTR CAT constructs. In addition, the pres- 
ence of IL-5 in the culture medium has been found to activate 
eosinophils (10, 11) and, by analogy with macrophages (12), 
this would be expected to enhance HIV replication within 
them. 
We found that CD4 expression by eosinophil precursors 
was greatest early in their maturation, with only very weak 
expression after 28 d in culture. This decline in CD4 expres- 
sion occurred in the absence of HIV which, itself, is known 
to downregulate CD4 expression on infected cells (13). We, 
therefore, inoculated the cultures with HIV within the first 
21 d in order to maximize the chance of achieving infection, 
although in vitro infection by HIV-1 of a purified CD34 + / 
CD4- myeloid progenitor population has been reported (14, 
15), suggesting that CD4 expression may not be necessary. 
Although only up to 4% of eosinophils in culture xpressed 
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HIV antigens or RNA, none of the other contaminating cells, 
which comprised <5% of the total, were infected, confirming 
that the viral activity detected in the culture supernatants 
was due to viral replication within eosinophils. Typical bi- 
lobed nuclear morphology was observed in all eosinophils 
after day 49 in culture. The increase in RT and p24 activity 
within the culture supernatant between days 49 and 63 in 
culture (days 35-49 after inoculation) provides strong evi- 
dence of continuing HIV replication in such mature cells. 
The ability of RF and RUT, but not 11113, strains of HIV-1 
to infect eosinophils suggests that, as for macrophages (16) 
and megakaryocytes (17), there may be strains of HIV with 
tropism for eosinophils. The latter is a laboratory adapted 
T lymphocyte tropic strain, which failed to infect CD34 § 
myeloid precursors in vitro (15). 
Eosinophils are known to have many similarities to mac- 
rophages, including their tropism for the skin and mucosal 
tissues and their activation by cytokines (18). Like macro- 
phages, they may also be a major reservoir for HIV, but fur- 
ther studies will be required to elucidate their role in vivo. 
We thank Glaxo Group Research Ltd. (Greenford, UK) for the gift of recombinant human II.-5, Dr. 
S. Patterson (CRC, Harrow, UK) for the HIV-1 BH10 probe, and the MRC ADP for the supply of HIV-1 
isolates, mAbs and p24 antigen assay kits. We thank Dr. Gary Nabel for helpful discussion and advice. 
This work was supported by a grant from the Medical Research Council AIDS Directed Programme 
(MRC ADP). G. E. Gri~n acknowledges support from the Wellcome Trust, F. M. Gibson is supported 
by the Marrow Environment Fund, and C. J. Spry by the British Heart Foundation. 
Address correspondence to Andrew Freedman, Division of Communicable Diseases, St. George's Hospital 
Medical School, London SW17 ORE, UK. 
Received for publication 22 July 199I and in revised form 19 September I991. 
1. Dalgleish, A.G., C.L. Beverley, P.R. Clapham, M. Crawford, 
F. Greaves, and R.A. Weiss. 1984. The CD4 (T4) antigen is 
an essential component of the receptor for AIDS retrovirus. 
Nature (Lond.). 312:763. 
2. Lucey, D.R., D.I. Dorsky, A. Nicholson-Weller, and P.E WeUer. 
1989. Human eosinophils express CD4 protein and bind human 
immunodeficiency virus 1 gp120, j. Ex F Med. 169:327. 
3. Sheff, D.M., W.F. Owen, Jr., and K.F. Austen. 1991. Eosino- 
phil phenotypes and LTC4 generation i vitro and in hyper- 
eosinophilic states. Adv. Prostaglandin Thromboxane Leuleotriene 
Res. 21B:481. 
4. Conrad, M.E. 1971. Hematologic manifestations of parasitic 
infections. Strain. Hematol. 8:267. 
5. Clutterbuck, E.J., E.M.A. Hirst, and C.J. Sanderson. 1989. 
Human interleukin-5 (IbS) regulates the production of eo- 
sinophils in human bone marrow cultures: comparison a d in- 
teraction with IIA, 11,-3, Ib6, and GMCSF. Blood. 73:1504. 
6. Cordell, J., B. Falini, W. Erber, A. Ghosh, Z. Abdulaziz, S. 
Macdonald, K. Pulford, H. Stein, and D. Mason. 1984. Im- 
munoenzymatic labelling of monoclonal ntibodies u ing im- 
mune complexes ofalkaline phosphatase anti-alkaline phospha- 
tase (APAAP). J. Histochem. Cytochem. 32:219. 
7. Patterson, S. J. Gross, and A.D.B. Webster. 1989. DNA probes 
bind non-specifically to eosinophils during in situ hybridiza- 
tion: carbol chromotrope blocks binding to eosinophils but 
does not inhibit hybridization tospecific nucleotide s quences. 
J. Virol. Methods. 23:105. 
8. Hoffman, A., 13. Banapeur, and J. Levy. 1985. Characteriza- 
tion of the AIDS-associated retrovirus reverse transcriptase and 
optimal conditions for its detection i  virions. Virology. 147:326. 
9. Hansel, T.T., J.D. Pound, and R.A. Thompson. 1990. Isola- 
tion of eosinophils from human blood. J. Immunol. Methods. 
127:153. 
10. Rothenberg, M.E., J. Petersen, and R.L. Stevens. 1989. 11.-5 
dependent conversion fnormodense human eosinophils tothe 
hypodense phenotype using 3T3 fibroblasts for enhanced via- 
bility, accelerated hypodensity, and sustained antibody-depen- 
dent cytotoxicity. J. Immunol. 143:2311. 
11. Fujisawa, T., R. Abu-Ghazaleh, H. Kita, C.J. Sanderson, and 
G.J. Gleich. 1990. Regulatory effect of cytokines on eosino- 
phil degranulation. J. Immunol. 144:642. 
12. Griffin, G.E., K. Leung, T.M. Folks, S. Kunkel, and G.J. Nabel. 
1989. Activation of HIV gent expression during monocyte 
differentiation byinduction of NF-IcB. Nature (Lond.). 339:70. 
13. Stevenson, M., X. Zhang, and D.J. Volsky. 1987. Downregu- 
lation of cell surface molecules during noncytopathic infection 
ofT cells with human immunodeficiency virus.J. Virol. 61:3741. 
14. Folks, T.M., S.W. Kessler, J.M. Orenstein, J.S. Justement, E.S. 
Jaffe, and A.S. Fauci. 1988. Infection and replication of HIV-1 
in purified progenitor cells of normal human bone marrow. 
Science (Wash. DC). 242:919. 
15. Kitano, K., C.N. Abboud, D.H. Ryan, S.G. Quan, G.C. 
Baldwin, and D.W. Golde. 1991. Macrophage-active colony- 
stimulating factors enhance human immunodeficiency virus 
type 1 infection in bone marrow stem cells. Blood. 77:1699, 
16. Cordonnier, A., L. Montagnier, and M. Emerman. 1989. Single 
amino acid changes inHIV envelope affect viral tropism and 
receptor binding. Nature (Lond.). 340:571. 
17. Sakaguchi, M., T. Sato, andJ.E. Groopman. 1991. Human im- 
munodeficiency virus infection of megakaryocytic cells. Blood. 
77:481. 
18. Weller, P.F. 1991. The immunobiology ofeosinophils. N. Engl. 
J. Ailed. 324:1110. 
1664 Human Immunodeficiency Virus Infection of Eosinophils 
